LOPW
ABBV icon

Live Oak Private Wealth’s AbbVie ABBV Stock Holding History

Live Oak Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.89M Sell
17,877
-208
-1% -$46.1K 0.54% 57
2025
Q4 		$4.13M Sell
18,085
-70
-0.4% -$15.9K 0.56% 53
2025
Q3 		$4.2M Hold
18,155
– – 0.59% 55
2025
Q2 		$3.37M Buy
18,155
+310
+2% +$57.6K 0.5% 59
2025
Q1 		$3.74M Buy
17,845
+50
+0.3% +$9.72K 0.61% 54
2024
Q4 		$3.16M Sell
17,795
-639
-3% -$117K 0.53% 55
2024
Q3 		$3.64M Sell
18,434
-936
-5% -$175K 0.59% 56
2024
Q2 		$3.32M Sell
19,370
-327
-2% -$54.2K 0.57% 58
2024
Q1 		$3.59M Buy
19,697
+5
+0% +$862 0.62% 56
2023
Q4 		$3.05M Sell
19,692
-248
-1% -$36.2K 0.57% 53
2023
Q3 		$2.97M Sell
19,940
-232
-1% -$34.1K 0.63% 49
2023
Q2 		$2.72M Sell
20,172
-19
-0.1% -$2.79K 0.54% 53
2023
Q1 		$3.22M Sell
20,191
-467
-2% -$71.4K 0.67% 50
2022
Q4 		$3.34M Sell
20,658
-325
-2% -$49.8K 0.69% 49
2022
Q3 		$2.82M Buy
20,983
+766
+4% +$110K 0.63% 57
2022
Q2 		$3.1M Buy
20,217
+1,748
+9% +$267K 0.65% 59
2022
Q1 		$2.99M Sell
18,469
-2,000
-10% -$291K 0.58% 60
2021
Q4 		$2.77M Sell
20,469
-110
-0.5% -$13K 0.52% 59
2021
Q3 		$2.22M Buy
20,579
+2,829
+16% +$323K 0.45% 60
2021
Q2 		$2M Buy
17,750
+38
+0.2% +$4.28K 0.44% 59
2021
Q1 		$1.92M Sell
17,712
-163
-0.9% -$17.4K 0.47% 58
2020
Q4 		$1.92M Buy
17,875
+2,020
+13% +$194K 0.54% 56
2020
Q3 		$1.39M Sell
15,855
-76
-0.5% -$7.16K 0.48% 58
2020
Q2 		$1.56M Buy
+15,931
New +$1.4M 0.57% 57

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Live Oak Private Wealth's ABBV Position: Q1 2026 in Review

Live Oak Private Wealth reduced its AbbVie (ABBV) stake by 1.2% in Q1 2026, selling an estimated $46.1K and leaving 17,877 shares worth $3.89M. The position accounts for 0.54% of the portfolio, ranked #57.

Live Oak Private Wealth first reported a position in ABBV in Q2 2020 and has held it in 24 quarters since. The position peaked at $4.2M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Live Oak Private Wealth held 17,877 shares of AbbVie worth $3.89M as of Q1 2026.
  • Live Oak Private Wealth sold 208 AbbVie shares in Q1 2026, an estimated $46.1K.
  • AbbVie made up 0.54% of Live Oak Private Wealth's portfolio in Q1 2026, its #57 holding.
  • Live Oak Private Wealth first reported a position in AbbVie in Q2 2020 and has held it in 24 quarters since.
  • Live Oak Private Wealth's AbbVie position peaked at $4.2M in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Live Oak Private Wealth's 13F filing for Q1 2026, filed 20 Apr 2026.